{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:34:31Z","timestamp":1791646471511,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd012406","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000}}],"reference-count":82,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012406.pub2","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T16:16:18Z","timestamp":1521130578000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Macrolide antibiotics for bronchiectasis"],"prefix":"10.1002","volume":"2018","author":[{"given":"Carol","family":"Kelly","sequence":"first","affiliation":[{"name":"Edge Hill University; Faculty of Health and Social Care; Ormskirk UK"},{"name":"Edge Hill University; Postgraduate Medical Institute; Ormskirk UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Chalmers","sequence":"additional","affiliation":[{"name":"University of Dundee, Ninewells Hospital and Medical School; Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Crossingham","sequence":"additional","affiliation":[{"name":"East Lancashire Hospitals NHS Trust; Blackburn Lancashire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Relph","sequence":"additional","affiliation":[{"name":"Edge Hill University; Faculty of Health and Social Care; Ormskirk UK"},{"name":"Edge Hill University; Postgraduate Medical Institute; Ormskirk UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert M","family":"Felix","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS); Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Evans","sequence":"additional","affiliation":[{"name":"Hemel Hempstead Hospital; Thoracic Medicine; Hillfield Road Hemel Hempstead Herts UK HP2 4AD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Milan","sequence":"additional","affiliation":[{"name":"Lancaster University; Medical School; Lancaster UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Spencer","sequence":"additional","affiliation":[{"name":"Edge Hill University; Faculty of Health and Social Care; Ormskirk UK"},{"name":"Edge Hill University; Postgraduate Medical Institute; Ormskirk UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"10.1002\/14651858.CD012406.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Altenburg J Wilms E Boersma W The relationship between serum- and sputum levels of azithromycin and clinical endpoints in bronchiectasis patients in bronchiectasis patients using maintenance treatment Pneumologie 2016 A3 10.1055\/s-0036-1592227","DOI":"10.1055\/s-0036-1592227"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Altenburg J Wolf R Go S van Rijn P Boersma W van der Werf T Changes of computed tomography features of bronchiectasis during one year of azithromycin treatment European Respiratory Journal 2016 OA278 10.1183\/13993003.congress-2016.OA278","DOI":"10.1183\/13993003.congress-2016.OA278"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0003|cit3","unstructured":"Altenburg J de Graaf C van der Werf T Boersma W Long term azithromycin treatment: A randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial European Respiratory Journal 2011 1924"},{"issue":"12","key":"10.1002\/14651858.CD012406.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Boersma WG Altenburg J Werf TS Evaluation of symptoms score and QoL in azithromycin maintenance treatment: results of a RCT trial in patients with bronchiectasis American Journal of Respiratory and Critical Care Medicine 2012 A3658","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A3658"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0006|cit6","unstructured":"Asintam P Kiranantawat N Juthong S Can roxithromycin improve quality of life in bronchiectatic patients? European Respiratory Journal 2012 P2168"},{"issue":"2","key":"10.1002\/14651858.CD012406.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treatments in Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012406.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/resp.12130","article-title":"Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis","volume":"18","author":"Diego","year":"2013","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0009|cit9","unstructured":"Juthong S Eiamsaard S The effects of roxithromycin as anti-inflammatory agent on clinical outcomes in patient with bronchiectasis: a double blinded randomized controlled study European Respiratory Journal 2011 455s"},{"issue":"5","key":"10.1002\/14651858.CD012406.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"11","key":"10.1002\/14651858.CD012406.pub2-BIB0011|cit11","first-page":"824","article-title":"[Impact of treatment with low dose roxithromycin on stable bronchiectasis]","volume":"35","author":"Liu","year":"2012","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua jiehe he huxi zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"708608","DOI":"10.1155\/2014\/708608","article-title":"Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis","volume":"2014","author":"Liu","year":"2014","journal-title":"Mediators of Inflammation"},{"issue":"8","key":"10.1002\/14651858.CD012406.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/resp.12375","article-title":"Efficacy of azithromycin in the treatment of bronchiectasis","volume":"19","author":"Lourdesamy Anthony","year":"2014","journal-title":"Respirology (Carlton, Vic.)"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Masekela R Anderson R Gongxeka H Steel HC Green RJ Lack of efficacy of erythromycin in children with human immunodeficiency virus-related bronchiectasis - a randomised controlled trial Paediatric Respiratory Reviews 2013 S82\/A009 12 http:\/\/dx.doi.org\/10.1016\/S1526-0542(13)70150-7","DOI":"10.1016\/S1526-0542(13)70150-7"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0015|cit15","first-page":"44","article-title":"Lack of efficacy of an immunomodulatory macrolide in childhood HIV-related bronchiectasis: a randomised, placebo-controlled trial","volume":"5","author":"Masekela","year":"2013","journal-title":"Journal of Antivirals and Antiretrovirals"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0016|cit16","unstructured":"Sadigov AS Mammadov GT Azythromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis: how we can improve the clinical features of severe disease? American Journal of Respiratory and Critical Care Medicine 2013 A3512"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0017|cit17","unstructured":"Burr L Rogers G Taylor S McGuckin M Serisier D Sub inhibitory erythromycin reduces the expression of key P. Aeruginosa virulence determinants in non-CF bronchiectasis subjects Respirology 2015 29"},{"issue":"10","key":"10.1002\/14651858.CD012406.pub2-BIB0018|cit18","first-page":"1697","article-title":"Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. An analysis from the bronchiectasis and low-dose erythromycin study trial","volume":"13","author":"Burr","year":"2016","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0019|cit19","unstructured":"Chen AC Martin MM Burr L Hasnain SZ Lourie R Bowler SD Clinical benefits of long-term, low-dose erythromycin in bronchiectasis are not due to anti-inflammatory effects American Journal of Respiratory and Critical Care Medicine 2013 A5970"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Rogers GB Bruce KD Martin ML Burr LD Serisier DJ Corrections. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial Lancet Respiratory Medicine 2015 e15","DOI":"10.1016\/S2213-2600(14)70213-9"},{"issue":"12","key":"10.1002\/14651858.CD012406.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Serisier DJ Bowler SD McGuckin M Chen A Lourie A Martin ML Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial American Journal of Respiratory and Critical Care Medicine 2012 A6862","DOI":"10.1001\/jama.2013.2290"},{"issue":"12","key":"10.1002\/14651858.CD012406.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD012406.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10096-015-2480-0","article-title":"Nasopharyngeal carriage and macrolide resistance in indigenous children with bronchiectasis randomized to long-term azithromycin or placebo","volume":"34","author":"Hare","year":"2015","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0025|cit25","unstructured":"Singleton R Morris P Leach A Roseby R White A Valery P Respirology 2008 A19"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0026|cit26","unstructured":"Singleton R Morris P Leach A Roseby R White A Valery PC BIS - Multi-centre bronchiectasis study: a collaborative and international study of bronchiectasis in indigenous children Respirology 2007 A 192"},{"issue":"8","key":"10.1002\/14651858.CD012406.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respiratory Medicine"},{"issue":"9842","key":"10.1002\/14651858.CD012406.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Wong CA Jayaram L Karalus N Eaton T Tong C Hockey H Azithromycin decreases exacerbations in non-cystic fibrosis bronchiectasis American Journal of Respiratory and Critical Care Medicine 2012a A3657","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A3657"},{"issue":"1","key":"10.1002\/14651858.CD012406.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of clarithromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcin","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"53","key":"10.1002\/14651858.CD012406.pub2-BIB0031|cit31","first-page":"14","article-title":"Bronchiectasis exacerbation study on azithromycin and amoxicillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial","volume":"14","author":"Chang","year":"2013","journal-title":"Trials"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012406.pub2-BIB0032|cit32","first-page":"617","article-title":"Preclinical and clinical studies on TE-031 (A-56268) in treatment of bacterial respiratory tract infections","volume":"36","author":"Kudo","year":"1988","journal-title":"Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD012406.pub2-BIB0033|cit33","first-page":"3027","article-title":"Clinical evaluation of TE-031 in the chronic respiratory infections [Japanese]","volume":"16","author":"Min","year":"1988","journal-title":"Japanese Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0034|cit34","first-page":"A168","article-title":"Efficacy of macrolide and theophylline in the management of bronchiectasis","volume":"10","author":"Ming","year":"2005","journal-title":"Respirology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012406.pub2-BIB0035|cit35","first-page":"715","article-title":"Preclinical and clinical studies on TE-031 (A-56268) in treatment of bacterial respiratory tract infections","volume":"36","author":"Rikitomi","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0036|cit36","first-page":"576","article-title":"Clinical studies of TE-031 (A-56268)","volume":"38","author":"Saito","year":"1988","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD012406.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.122.1.213","article-title":"Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion","volume":"122","author":"Tagaya","year":"2002","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0038|cit38","first-page":"544","article-title":"Clinical study on TE-031(A-56268) against respiratory infections","volume":"36","author":"Unoura","year":"1988","journal-title":"Physicians' Therapy Manual"},{"issue":"2","key":"10.1002\/14651858.CD012406.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0040|cit40","unstructured":"Tsang KW Ho PL Chan KN Ip M Lam WK Lam B Erythromycin (EM) reduces sputum volume and improves lung functions in bronchiectasis American Thoracic Society International Conference; 1998 April 24-29; Chicago 1998 A174"},{"issue":"8","key":"10.1002\/14651858.CD012406.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012406.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/13993003.01888-2015","article-title":"Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration","volume":"48","author":"Aliberti","year":"2016","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD012406.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD012406.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"Brodt","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD012406.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012406.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The Bronchiectasis Severity Index: an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012406.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5694\/j.1326-5377.2002.tb04733.x","article-title":"Bronchiectasis in indigenous children in remote Australian communities","volume":"177","author":"Chang","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"6","key":"10.1002\/14651858.CD012406.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Australian Lung Foundation","volume":"193","author":"Chang","year":"2010","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Gibson GJ Loddenkemper R Sibille Y Lundb\u00e4ck B editor(s) European Lung White Book: Respiratory Health and Disease in Europe. European Respiratory Society, 2013 https:\/\/www.erswhitebook.org\/","DOI":"10.1183\/09031936.00105513"},{"issue":"11","key":"10.1002\/14651858.CD012406.pub2-BIB0050|cit50","first-page":"1602","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0051|cit51","first-page":"e90047","article-title":"Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"3","author":"Gao","journal-title":"PLoS One"},{"issue":"1","key":"10.1002\/14651858.CD012406.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1183\/13993003.01567-2015","article-title":"Bronchiectasis: how to be an orphan with many parents?","volume":"47","author":"Goeminne","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0053|cit53","unstructured":"McMaster University (developed by Evidence Prime) GRADEproGDT 2015"},{"issue":"3","key":"10.1002\/14651858.CD012406.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/1817-1737.82443","article-title":"Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis","volume":"6","author":"Habesoglu","year":"2011","journal-title":"Annals of Thoracic Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012406.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011825","article-title":"Adverse events in patients taking macrolide antibiotics versus placebo for any indication","author":"Hansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012406.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.rmed.2014.09.005","article-title":"Long term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions","volume":"108","author":"Haworth","year":"2014","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0057|cit57","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8","key":"10.1002\/14651858.CD012406.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001392.pub3","article-title":"Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults","author":"Hnin","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012406.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40258-013-0027-z","article-title":"Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective","volume":"11","author":"Joish","year":"2013","journal-title":"Applied Health Economics and Health Policy"},{"issue":"4","key":"10.1002\/14651858.CD012406.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.11-0679","article-title":"The burden of disease in pediatric non-cystic fibrosis bronchiectasis","volume":"141","author":"Kapur","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1002\/14651858.CD012406.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e1000883","DOI":"10.1371\/journal.ppat.1000883","article-title":"Quorum sensing inhibition selects for virulence and co-operation in Pseudomonas aeruginosa","volume":"6","author":"Kohler","year":"2010","journal-title":"PLoS Pathogens"},{"issue":"4","key":"10.1002\/14651858.CD012406.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1620\/tjem.222.237","article-title":"High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program","volume":"222","author":"Kwak","year":"2010","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012406.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0064|cit64","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012406.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD012406.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society Guidelines for Non-CF Bronchiectasis","volume":"65(Suppl 1)","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD012406.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD012406.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1183\/13993003.00954-2015","article-title":"Bronchiectasis in Germany: a population-based estimation of disease prevalence","volume":"46","author":"Ringshausen","year":"2015","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.rmed.2010.02.022","article-title":"Trends in bronchiectasis mortality in England and Wales","volume":"104","author":"Roberts","year":"2010","journal-title":"Respiratory Medicine"},{"issue":"13","key":"10.1002\/14651858.CD012406.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012406.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD012406.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007","volume":"142","author":"Seitz","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD012406.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risk of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respiratory Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012406.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \"too high\" for a developed country","volume":"90","author":"Twiss","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"7","key":"10.1002\/14651858.CD012406.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010337.pub2","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012406.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clinical Pulmonary Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012406.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008695.pub2","article-title":"Short courses of antibiotics for children and adults with bronchiectasis","author":"Wurzel","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012406.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","article-title":"Macrolides from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases","volume":"68","author":"Zarogoulidis","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD012406.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012406","article-title":"Macrolide antibiotics for non-cystic fibrosis bronchiectasis","author":"Kelly","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012406.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T01:39:48Z","timestamp":1719884388000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012406.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":82,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012406.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]}}}